We are live on ! Find out more
RJT

Raymond James Trust Portfolio holdings

AUM $4.6B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+2.61%
1 Year Est. Return
+33.54%
3 Year Est. Return
+41.33%
5 Year Est. Return
+111.23%
10 Year Est. Return
+235.1%
AUM
$1.34B
AUM Growth
+$22.1M
Cap. Flow
-$5.89M
Cap. Flow %
-0.44%
Top 10 Hldgs %
17.53%
Holding
751
New
49
Increased
312
Reduced
289
Closed
31

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$2.2M
2
VEA icon
Vanguard FTSE Developed Markets ETF
VEA
+$1.46M
3
TGT icon
Target
TGT
+$1.36M
4
QCOM icon
Qualcomm
QCOM
+$1.18M
5
GE icon
GE Aerospace
GE
+$1.01M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$5.23M
2
JNJ icon
Johnson & Johnson
JNJ
+$5.15M
3
IBM icon
IBM
IBM
+$3.32M
4
CPB icon
Campbell Soup
CPB
+$2.43M
5
BMY icon
Bristol-Myers Squibb
BMY
+$2.05M

Sector Composition

Rank Sector Weight
1 Financials 12.84%
2 Healthcare 12.71%
3 Technology 11.57%
4 Consumer Staples 9.8%
5 Industrials 8.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GS icon
151
Goldman Sachs
GS
$313B
$1.98M 0.15%
8,914
+39
+0.4% +$8.67K
PX
152
DELISTED
Praxair Inc
PX
$1.96M 0.15%
14,802
+139
+0.9% +$17.8K
RTN
153
DELISTED
Raytheon Company
RTN
$1.93M 0.14%
11,968
-251
-2% -$39.8K
ESRX
154
DELISTED
Express Scripts Holding Company
ESRX
$1.92M 0.14%
30,004
+1,003
+3% +$63K
LYB icon
155
LyondellBasell Industries
LYB
$19.5B
$1.9M 0.14%
22,544
+930
+4% +$77.2K
TMO icon
156
Thermo Fisher Scientific
TMO
$211B
$1.9M 0.14%
10,884
+144
+1% +$24.2K
AZN icon
157
AstraZeneca
AZN
$263B
$1.87M 0.14%
27,458
+741
+3% +$48.4K
VCSH icon
158
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$1.85M 0.14%
23,081
+2,456
+12% +$196K
EPP icon
159
iShares MSCI Pacific ex Japan ETF
EPP
$2.18B
$1.85M 0.14%
41,494
– –
MA icon
160
Mastercard
MA
$477B
$1.84M 0.14%
15,145
+88
+0.6% +$10.4K
TWX
161
DELISTED
Time Warner Inc
TWX
$1.84M 0.14%
18,318
-1,304
-7% -$129K
NVDA icon
162
NVIDIA
NVDA
$5.01T
$1.84M 0.14%
508,480
-3,760
-0.7% -$11.9K
COP icon
163
ConocoPhillips
COP
$147B
$1.83M 0.14%
41,593
-2,903
-7% -$135K
LOW icon
164
Lowe's Companies
LOW
$116B
$1.82M 0.14%
23,450
+725
+3% +$59.3K
GILD icon
165
Gilead Sciences
GILD
$161B
$1.81M 0.14%
25,626
-260
-1% -$17.3K
AFL icon
166
Aflac
AFL
$63.9B
$1.81M 0.14%
46,608
+6,142
+15% +$231K
CME icon
167
CME Group
CME
$92.2B
$1.79M 0.13%
14,328
+356
+3% +$42.6K
CCI icon
168
Crown Castle
CCI
$32.7B
$1.78M 0.13%
17,796
+1,146
+7% +$113K
DE icon
169
Deere & Co
DE
$170B
$1.78M 0.13%
14,384
+613
+4% +$71.9K
SPGI icon
170
S&P Global
SPGI
$126B
$1.76M 0.13%
12,034
-207
-2% -$28.7K
ETN icon
171
Eaton
ETN
$157B
$1.74M 0.13%
22,400
+334
+2% +$25.5K
AEP icon
172
American Electric Power
AEP
$73.7B
$1.74M 0.13%
25,054
+2,113
+9% +$147K
CL icon
173
Colgate-Palmolive
CL
$72.6B
$1.73M 0.13%
23,373
+1,966
+9% +$146K
BDJ icon
174
BlackRock Enhanced Equity Dividend Trust
BDJ
$1.7B
$1.72M 0.13%
195,405
-7,516
-4% -$65K
MCK icon
175
McKesson
MCK
$98.5B
$1.71M 0.13%
10,390
+2,081
+25% +$316K
5 6
7
8 9

Similar funds

ECU
Eisler Capital (US) New York $4.67B AUM 35.2% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
WPL
Winder Pte Ltd Singapore $5.59B AUM 41.5% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
SA
SpiderRock Advisors Wilimington, Delaware $6.29B AUM
CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return

Raymond James Trust's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James Trust held 751 positions worth $1.34B, up 1.7% from $1.32B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James Trust's Q2 2017 filing shows 49 new, 312 increased, 289 reduced and 31 closed positions. Its largest new stake was AutoZone: 801 shares worth $457K. The largest sale was Merck, an estimated $5.23M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 12% a quarter earlier, followed by Healthcare and Technology.

  • Raymond James Trust's largest Q2 2017 buy was AutoZone: 801 shares worth $457K.
  • Raymond James Trust added most to Alphabet (Google) Class C in Q2 2017, an estimated $2.2M increase.
  • Raymond James Trust's biggest Q2 2017 reduction was Merck, cutting an estimated $5.23M.
  • Raymond James Trust fully exited Campbell Soup in Q2 2017, selling an estimated $2.43M.
  • Raymond James Trust's ten largest holdings make up 18% of its $1.34B portfolio in Q2 2017.
  • Raymond James Trust opened 49 new positions and closed 31 in Q2 2017.
  • Raymond James Trust's portfolio value rose 1.7% quarter-over-quarter to $1.34B.

Based on Raymond James Trust's 13F filing for Q2 2017, filed 10 Aug 2017.